Side-by-side comparison of AI visibility scores, market position, and capabilities
Zerodha is India's largest discount broker and most profitable bootstrapped fintech, with ₹9,372 Cr revenue and ₹5,496 Cr profit in FY24, serving 7.5M+ active investors.
Zerodha is India's largest stock brokerage and the most successful bootstrapped fintech company in the country. Founded in 2010 by Nithin Kamath and Nikhil Kamath, Zerodha disrupted India's brokerage industry by introducing a flat-fee model—charging ₹20 per trade regardless of size—versus the percentage-of-trade-value model of traditional brokers. This pricing innovation made stock trading accessible to a much broader population of retail investors and drove Zerodha to become the country's largest broker by active client count.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.